Jose Luis Sánchez-Iglesias

Jose Luis Sánchez-Iglesias

Auto-generated profile, based on publicly available information

Jose Luis Sánchez-Iglesias

Department of Gynecologic Oncology Vall d'Hebron University Hospital Barcelona Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2019 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
JSJosé-Luis Sánchez-Iglesias
José-Luis Sánchez-Iglesias
SCSira Capote
Sira Capote
MCMontserrat Cubo-Abert
Montserrat Cubo-Abert
MCMelchor Carbonell-Socias
Melchor Carbonell-Socias
SCSílvia Cabrera
Sílvia Cabrera
Antonio Gil-MorenoAntonio Gil-Moreno
Antonio Gil-Moreno

18 July 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
JSJ.L. Sánchez-Iglesias
J.L. Sánchez-Iglesias
VBVicente Bebia
Vicente Bebia
EGE. Gimenez
E. Gimenez
MHMarta B. Aller Hernández
Marta B. Aller Hernández
MBMelissa Bradbury
Melissa Bradbury
YCY. Cossio-Gil
Y. Cossio-Gil

26 March 2024 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
JSJosé Luis Sánchez‐Iglesias
José Luis Sánchez‐Iglesias
CMClara Morales‐Coma
Clara Morales‐Coma
LMLucas Minig
Lucas Minig
VLVíctor Lago
Víctor Lago
SDSantiago Domingo
Santiago Domingo
TGthe SEGO Spain‐GOG Group
the SEGO Spain‐GOG Group
Introduction: Serum levels of procalcitonin and C‐reactive protein (CRP) have been used to predict anastomotic leakage after colorectal surgery, but information is scarce in advanced ovarian cancer (AOC) surgery with bowel resection. This study aimed to assess the predictive value of procalcitonin and CRP in detecting anastomotic leakage after AOC surgery with bowel resection. The study also aimed to determine the optimal postoperative reference values and the best day for evaluating these markers.Material and methods: This prospective, observational and multicentric trial included 92 patients with AOC undergoing debulking surgery with bowel resection between 2017 and 2020 in 10 reference hospitals in Spain. Procalcitonin and CRP levels were measured at baseline and on postoperative days 1–6. Receiver operating characteristic analysis was performed to evaluate the predictive value of procalcitonin and CRP at each postoperative day. Sensitivity, specificity, positive and negative predictive values were calculated.Results: Anastomotic leakage was detected in six patients (6.5%). Procalcitonin and CRP values were consistently higher in patients with anastomotic leakage at all postoperative days. The maximum area under the curve (AUC) for procalcitonin was observed at postoperative day 1 (AUC = 0.823) with a cutoff value of 3.8 ng/mL (83.3% sensitivity, 81.3% specificity). For CRP, the maximum AUC was found at postoperative day 3 (AUC = 0.833) with a cutoff level of 30.5 mg/dL (100% sensitivity, 80.4% specificity).Conclusions: Procalcitonin and C‐reactive protein are potential biomarkers for early detection of anastomotic leakage after ovarian cancer surgery with bowel resection. Further prospective studies with a larger sample size are needed to confirm these findings.

17 July 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JSJose Luis Sánchez-Iglesias
Jose Luis Sánchez-Iglesias
NGNatalia R. Gómez-Hidalgo
Natalia R. Gómez-Hidalgo
PAPEREZ-BENAVENTE ASUNCION
PEREZ-BENAVENTE ASUNCION
MCMelchor Carbonell-Socias
Melchor Carbonell-Socias
SMSusana Manrique-Muñoz
Susana Manrique-Muñoz
Antonio Gil-MorenoAntonio Gil-Moreno
Antonio Gil-Moreno

29 September 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
MRM. Vazquez Rojas
M. Vazquez Rojas
MGM. Gutiérrez-Barceló
M. Gutiérrez-Barceló
JSJ.L. Sánchez-Iglesias
J.L. Sánchez-Iglesias
SMS. Manrique-Muñoz
S. Manrique-Muñoz
APA. Pérez-Benavente
A. Pérez-Benavente
ISI. Salevsky-Muñoz
I. Salevsky-Muñoz